Search Results - avraham raz




3 Results Sort By:
Generation of gp78 null mice
Generation of gp78 null mice WSU Tech#: 15-1291 Technology: Generation of the first preclinical experimental model system for gp78-/- C57BL/6 mice, which spontaneously develops age-related nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), linking endoplasmic reticulum-associated degradation (ERAD) to hepatosteatosis, cirrhosis,...
Published: 5/19/2017   |   Inventor(s): Avraham Raz, Andrei Golovko
Keywords(s):  
Category(s): Animal models, Biology, Biomedical, Biotechnology, Drug Delivery, Drug Discovery, Drug Screening, Genomics/Genetics, Life Science, Oncology, Research tools
Level of Galectin-3 protein in human blood improves PSA test results
Level of Galectin-3 Protein in Human Blood Improves PSA Test Results WSU Tech#: 13-1133 Technology Summary: For determining prostate cancer aggressiveness, PSA alone is not reliable, as it gives a high number of false positive and false negative results. There are about 25,000 publications on other markers in addition to PSA and as of yet, none...
Published: 5/19/2017   |   Inventor(s): Avraham Raz, Vitaly Balan, Elisabeth Heath, Lance Heilbrun
Keywords(s):  
Category(s): Medical, Biomedical, Diagnostics, Oncology
A Diagnostic Marker for Matrix Metalloprotease (MMP)-2 and -9 Activity in Cancer Tissue
This invention is a new and simple method for the identification of active versus latent matrix metalloprotease enzymes (MMPs) in tissue. Background & Unmet Need: MMPs are involved in tumor progression and therefore are targets for anti-cancer drug therapies. However, most drug therapies directed at inhibition of MMPs have failed because there...
Published: 5/6/2010   |   Inventor(s): Avraham Raz, Rafael Fridman, Pratima Nangia-Makker
Keywords(s): Biomarker, Cancer, Diagnostics, Enzyme, Method
Category(s): Life Science, Oncology, Research tools, Antibodies, Therapeutics, Diseases